CellSource (4880) · FactFirst stated

Raising Capital Through a Public Offering

First written in FY2023. . Latest entry: FY2023.

1entries

1years

0from disclosures

How it moved

Same theme, other companies

Raising Funds for Growth Investments and Capital Strengthening through a Public Offering and Third-Party Allotment (Including an Overseas Offering)A theme 57 companies write about · 0 as a headwind · 57 as a tailwind

The whole theme swung hardest in 2023: 2 of 14 companies on the "Worse" side.

5 other companies' latest entry also says "First stated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.

Showing 14 of the 57 companies compared. The sentences above are computed from all 57.

Full recordFilings, disclosures and news, newest first

FY2023First statedAnnual report
「We issued 700,000 shares offered through a public offering, with 5 October 2023 as the payment date.」
The public offering resulted in the issuance of 700,000 shares, increasing both stated capital and capital surplus by ¥730.184 million.

Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next

No upcoming earnings preview for CellSource yet.

News

No news is linked to this thread yet. When an article touches it, it will appear here by date.